• Follow the Money: AI-Powered Cell Therapies, Cancer Risk Assessment, More

    Bio-IT World | Outpace Bio will advance multiple programmed T cell product candidates to early clinical proof-of-concept for the treatment of solid tumors; Foresight Diagnostics plans to accelerate the clinical development and commercialization of their cancer recurrence testing platform, PhasED-Seq; PreciseDx plan to expand commercialization efforts for PreciseBreast risk assessment, an AI-Powered test used to assess early-stage invasive breast cancer risk; and more.

    Aug 29, 2024

  • Dovetail Genomics, Goenomics GmbH Partnership, Danaher Acquires Genedata, Andelyn Biosciences License Agreement With Broad Institute, More

    Bio-IT World |Dovetail Genomics has formed a partnership with Goenomics GmbH to deliver an enhanced genome assembly service with the fastest turnaround time and most complete annotation available in the industry; Genedata has been acquired by Danaher; Andelyn Biosciences has entered into a License Agreement with the Broad Institute of MIT and Harvard to expand its AAV Curator Platform offering to include MyoAAV plasmids; and more.

    Aug 28, 2024

  • Panel Explores the Rapidly Evolving Field of Genetic Medicines

    Bio-IT World | In a panel discussion at last week’s Bioprocessing Summit, four leaders in genetic medicine shared insights into the rapidly evolving world of gene editing and its potential to revolutionize the treatment of complex diseases. In a panel discussion at last week’s Bioprocessing Summit, four leaders in genetic medicine shared insights into the rapidly evolving world of gene editing and its potential to revolutionize the treatment of complex diseases.

    Aug 27, 2024

  • The Art of Building Techbio Teams

    Bio-IT World | The biotech industry is experiencing a significant shift as technology and biology converge. This intersection, often called Techbio, is opening up new possibilities for addressing health and environmental challenges.

    Aug 23, 2024

  • First Clinical Trial of ‘Paradoxical Intervention’ for Cancer to Begin Soon

    Bio-IT World | Cancer cells are “not like superheroes that have no vulnerabilities." Most current therapies try to block the signaling to prevent cancer’s uncontrolled division, but inevitably tumor cells resist the blockage and become far less responsive to subsequent therapy.

    Aug 21, 2024

  • Mice Cleared of Senescent Cells Shown to Die Healthier—Not Just Live Longer

    Bio-IT World | By treating a particular brand of senescent cells, it is now possible to live healthier for longer—at least in mice. If the findings can be translated to humans, that could mean an extra decade of healthiness. Plenty of medicines are already available to help people live longer, but not necessarily with vitality.

    Aug 20, 2024

  • Standardized R&D Data Exchange is Here. Let’s Embrace It.

    Bio-IT World | Life sciences companies have spent much time and treasure working to streamline and improve product development. The drivers have been many, but two have stood out. The first is a desire to improve efficiency and optimize cost, because it’s good for business and the pocketbooks of patients we ultimately serve. The second is to boost material traceability, because product quality depends on it—and regulators demand it.

    Aug 16, 2024